Assessing the Frequency, Type, and Severity of Drug-Induced Liver Injury with Azole Antifungal Drugs for Dermatophytosis.
TL;DR
This study strengthens the association of azole antifungals with mild biochemical liver abnormalities and infrequent DILI, and highlights a time-dependent effect and necessitates regular monitoring of LFTs during and after treatment.
Abstract
Objective
To determine the frequency, nature, and severity of drug-induced liver injury (DILI) among patients receiving azole antifungal agents for superficial fungal skin infections. STUDY
Design
A descriptive study. Place and Duration of the Study: Department of National Institute of Liver and Gastrointestinal Diseases, Dow University Hospital, Dow University of Health Sciences, Ojha Campus, Karachi, Pakistan, from July 2024 to January 2025. METHODOLOGY A total of 116 patients were enrolled, and baseline liver function tests (LFTs) were performed at the start of treatment and repeated at 4 and 6 weeks. Those who developed deranged LFTs were referred to the hepatology clinic. Additional investigations were done for those who developed deranged LFTs. DILI was defined according to international criteria and classified using the R-value. The Wilcoxon signed-rank and Friedman tests were used for statistical analysis.
Results
Among 116 patients with tinea corporis/cruris, 102 (87.9%) received itraconazole and 14 (12.1%) voriconazole. Liver function derangement occurred in 65 (56%) patients, of whom only 10 (8.6%) patients developed DILI, predominantly a cholestatic pattern. Six out of 10 DILI cases occurred among itraconazole-treated patients. A short-term (4-week) course showed significant increases in alkaline phosphatase (ALP) and aspartate aminotransferase (AST) levels (p = 0.012), whereas 6-week treatment led to marked increases in alanine aminotransferase (ALT), ALP, and AST levels (p <0.001).
Conclusion
This study strengthens the association of azole antifungals with mild biochemical liver abnormalities and infrequent DILI. A short- term course of azoles causes a rise in ALP and AST, while longer courses cause a more comprehensive rise in LFTs. Thus, this highlights a time-dependent effect and necessitates regular monitoring of LFTs during and after treatment. KEY WORDS Drug-induced liver injury, Liver function tests, Azoles, Dermatophytosis, Tinea corporis/cruri, R-value, Cholestasis.